W. Elakel
9 Papers
1 Citations
W. Elakel is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 7 publications.
Chat about Author
Papers
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set
Jake R. Morgan,Elizabeth Marsh,Alexandra A. Savinkina,Sonjelle Shilton,Shaun Shadaker,Tengiz Tsertsvadze,George Kamkamidze,Maia Alkhazashvili,Tim Morgan,Pam Belperio,L. Backus,Waheed Doss,Gamal Esmat,Mohamed Hassany,Aisha Elsharkawy,W. Elakel,Mai Mehrez,Graham R. Foster,K. Wose,Kara W. Chew,Charles Chasela,Ian Sanne,Yin M Thanung,Anne Loarec,Khawar Aslam,Suna Balkan,Philippa Easterbrook,Benjamin P. Linas +27 more
TL;DR: An assay with a level of detection of 1000 IU/mL or greater may miss a proportion of those with low‐level treatment failure, and an acceptable LLoD for detectable HCV viraemia as a test for cure, 12 weeks post‐treatment (SVR12 is determined.
Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt.
Hadeel Gamal Eldeen,Mohamed Hassany,W. Elakel,Mohamed Abou-Elwafa Abdallah,Wael Abdel-Razek,Yehia ElShazly,Hany Dabbous,Manal Hamdy El-Sayed,Magdy El-Serafy,Imam Waked,Gamal Esmat,Wahid Doss,Ahmed M. Hashem +12 more
TL;DR: In this article , a multicenter nationwide study aimed to assess the seroprevalence of hepatitis B virus (HBV) among Egyptian patients with hepatitis C virus (HCV) and its possible risk factors.
3
Covid-19 pandemic in Egyptian children with liver diseases: Incidence and impact on health care service delivery in a low/middle income country
TL;DR: In this paper , a cross-sectional analytical study conducted at the Pediatric Hepatology Unit, Cairo University Children's Hospital utilized a questionnaire to determine the incidence of COVID-19 in patients with liver diseases and the impact of the pandemic on the patients' liver condition and health care service delivery.
2
Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study.
Mohamed El-Kassas,W. Elakel,Mohamed Alboraie,Reem Ezzat,Sara M. Abdelhakam,Mohamed Hassany,Zainab A. Ali-Eldin,Ahmed F Sherief,Ayman Yosry,Magdy El-Serafy,Manal H El-Sayed,Imam Waked,Wahid Doss,Gamal Esmat +13 more
TL;DR: In this paper , the authors used Lok index, Bonacini score, liver stiffness, FIB-4, Baveno, and extended BAVO VI to predict esophageal varices.
2
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.
Mohammad El-Sayed,Magdy Elserafy,Maissa El Raziky,W. Elakel,Yasmin Saad,Tarek Fayad,Mohamed Korany,Mai Mehrez,Rabab Salama,Maged Mahrous,A Zaki,Mohamed Hassany,Islam Ammar,Kadry Elsaeed,Yehia Elshazly,Wahid Doss +15 more
TL;DR: Ombitasvir/paritaprevir/ritonavir-based therapy in chronic HCV patients with CKD is highly effective, with minimal side effects despite ribavirin-induced anemia as mentioned in this paper .
1